study demonstrated that ipamorelin: Released GH in a dose-dependent manner Did not significantly elevate cortisol levels, even at high doses Did not significantly elevate prolactin levels Did not significantly affect ACTH, FSH, LH, or TSH (4) This selectivity gives ipamorelin a notably clean side-effect profile compared to other GH secretagogues
Encouraging ongoing research into the benefits and risks of Ozempic to inform future clinical guidelines and patient care practices
Research shows liver enzymes often improve during GLP-1 treatment as weight loss reduces hepatic fat accumulation, but only a documented baseline makes that improvement verifiable
3 seller in this category, Good Culture LLC, enjoyed excellent year-over-year success, according to the research firm
Show Sources Photo Credit: Moment/Getty Images SOURCES: Cleveland Clinic: GLP-1 Agonists, Dehydration, Ozempic Face: What It Is and How To Avoid It, Elastin, Sebaceous Glands, Telogen Effluvium, Can Ozempic Cause Hair Loss? What the SPF in Your Sunscreen Means, Best Ingredients and Products for Your Anti-Aging Skin Care Routine, Subcutaneous Fat. Clinical, Cosmetic and Investigational Dermatology: Dietary water affects human skin hydration and biomechanics. NIH Diseases: A Closer Look at the Dermatological Profile of GLP-1 Agonists. NIH Endocrine: GLP-1RA and the possible skin aging. George Washington University: Media Tip Sheet: The Impact GLP-1 Drugs Have on Your Skin, Study Links Popular GLP-1 Weight-Loss Drugs to Increased Risk of Hair Loss. UCLA Health: Ozempic face (and other GLP-1 side effects). Journal of Clinical and Aesthetic Dermatology: A Review of Glucagon-like Peptide-1 in Dermatology. Harvard Health: GLP-1 diabetes and weight-loss drug side effects: Ozempic face and more. JAMA Internal Medicine Patient Page: I Am Taking a GLP-1 Weight-Loss MedicationWhat Should I Know? American Journal of Physiology Regulatory, Integrative and Comparative Physiology: Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake. Mayo Clinic: Psoriasis. Journal of Cellular Signaling: A Discussion on the Relationship between Skin Lipid Metabolism and Whole-Body Glucose and Lipid Metabolism: Systematic Review. Cureus: Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. JAAD International: Increased Incidence and Risk of Hair Loss with GLP-1 Receptor Agonists: A RealWorld Multicenter TrinetX Cohort Study. American Academy of Dermatology Association: "Dermatologists' Top Tips for Relieving Dry Skin.
